Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7

Citation
L. Gallacher et al., Isolation and characterization of human CD34(-)Lin(-) and CD34(+)Lin(-) hematopoietic stem cells using cell surface markers AC133 and CD7, BLOOD, 95(9), 2000, pp. 2813-2820
Citations number
33
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BLOOD
ISSN journal
00064971 → ACNP
Volume
95
Issue
9
Year of publication
2000
Pages
2813 - 2820
Database
ISI
SICI code
0006-4971(20000501)95:9<2813:IACOHC>2.0.ZU;2-7
Abstract
Recent evidence indicates that human hematopoietic stem cell properties can be found among cells lacking CD34 and lineage commitment markers (CD34(-)L in(-)). A major barrier in the further characterization of human CD34(-) st em cells is the inability to detect this population using in vitro assays b ecause these cells only demonstrate hematopoietic activity in vivo, Using c ell surface markers AC133 and CD7, subfractions were isolated within CD34(- )CD38(-)Lin(-) and CD34(+)CD38(-)Lin(-) cells derived from human cord blood . Although the majority of CD34(-)CD38(-)Lin(-) cells lack AC133 and expres s CD7, an extremely rare population of AC133(+)CD7(-) cells was identified at a frequency of 0.2%. Surprisingly, these AC133(+)CD7(-) cells were highl y enriched for progenitor activity at a frequency equivalent to purified fr actions of CD34(+) stem cells, and they were the only subset among the CD34 (-)CD38(-)Lin(-) population capable of giving rise to CD34(+) cells in defi ned liquid cultures. Human cells were detected in the bone marrow of non-ob ese/ severe combined immunodeficiency (NOD/SCID) mice 8 weeks after transpl antation of ex vivo-cultured AC133(+)CD7(-) cells isolated from the CD34(-) CD38(-)Lin(-)population, whereas 400-fold greater numbers of the AC133(-)CD 7(-) subset had no engraftment ability. These studies provide novel insight s into the hierarchical relationship of the human stem cell compartment by identifying a rare population of primitive human CD34(-) cells that are det ectable after transplantation in vivo, enriched for in vitro clonogenic cap acity, and capable of differentiation into CD34(+) cells, (Blood, 2000;95:2 813-2820) (C) 2000 by The American Society of Hematology.